Kronos Bio is a biotechnology company focused on discovering and developing innovative therapeutics for cancer treatment. Utilizing a deep understanding of transcriptional regulation and cancer biology, the company aims to provide targeted therapies that address unmet medical needs, particularly for patients with difficult-to-treat malignancies.